The role of pattern recognition and autophagy in innate anti-bunyaviral immunity
模式识别和自噬在先天性抗布尼亚病毒免疫中的作用
基本信息
- 批准号:9917158
- 负责人:
- 金额:$ 52.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-23 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAntigensAntiviral AgentsAntiviral ResponseArbovirus InfectionsArthropodsAutophagocytosisBiochemicalBiologicalBunyaviridaeCell DeathCellsCellular biologyDataDrosophila genusEncephalitisExhibitsGenetic PolymorphismGenetic TranscriptionGoalsHumanImmune responseImmunityInfectionInfection ControlInnate Immune ResponseInnate Immune SystemInsect VectorsInsectaInterventionInvadedKnowledgeLa Crosse virusLigandsLinkMammalian CellMammalsMolecularNatural ImmunityNatureNeuraxisNeurogliaNeuronsOutcomeOutputPathogenesisPathway interactionsPattern RecognitionPattern recognition receptorPharmacologyReceptor SignalingResearchRift Valley fever virusRoleShapesSignal PathwaySignal TransductionSystemTLR2 geneTherapeuticTissuesTropismVaccinesVirusVirus Diseasesantiviral immunitybeta-Glucanscell typecombatdectin 1dimerhuman diseaseinsightnovelnovel strategiespathogenpathogenic virusprogramsreceptorresponsescreeningtissue tropismtreatment strategy
项目摘要
Summary
Innate immunity is the first line of defense against pathogens and is highly conserved from insects to
humans. While many key facets of the innate immune system have been elucidated, there is a fundamental gap
in our knowledge of the pathways that restrict arthropod-borne viral infections in the diverse target tissues that
are infected during the infection of the mammalian host. Importantly, a molecular understanding of these
mechanisms is essential to overcome the lack of effective antiviral therapeutics and combat human disease.
The Drosophila immune response is highly homologous to that of vector insects and additionally shares striking
similarities with mammalian innate immunity. Using the Drosophila system, we previously found that the
emerging bunyavirus Rift Valley Fever virus (RVFV) is sensed by the Drosophila Pattern recognition receptor
(PRR), Toll-7, which activates antiviral autophagy and that this is conserved in mammalian cells. We found that
TLR2-dependent antiviral autophagy can control RVFV in some cell types while in other cells engagement of
TLR2 leads to cell death. Moreover, we found that pharmacological activation of autophagy is restrictive against
RVFV in mammalian primary neurons, suggesting that this pathway may be harnessed for antiviral protection.
Since tissue-specific signaling of PRR pathways are poorly characterized we screened a panel of PRR agonists
for those that could block RVFV infection in neurons and in non-neuronal cells in parallel. We identified two
classes of antiviral PAMPs. First, we identified TLR2 agonists as antiviral in both cell types. Since
pharmacological activation of autophagy can protect primary mammalian neurons from infection, we suggest
that TLR2 activation may be harnessed to defend neurons from encephalitic viruses. Second, we identified
Dectin-1 agonists as specifically antiviral in neurons which will be further explored. Therefore, the long-term
objective of the proposed research is to understand the molecular mechanisms by which viral infections
are sensed and controlled by innate pathways and how this may be harnessed to induce protective
defenses in diverse cell types including neurons. To accomplish these goals, this application proposes two
specific aims: (1) to identify the mechanism by which RVFV is sensed by TLR2 leading to diverse outcomes,
autophagy or cell death; and (2) explore the PRR pathways that can control bunyaviruses in mature mammalian
neurons.
概括
先天免疫是对抗病原体的第一道防线,从昆虫到昆虫都高度保守。
人类。虽然先天免疫系统的许多关键方面已被阐明,但仍存在根本性差距
根据我们对限制不同靶组织中节肢动物传播的病毒感染的途径的了解,
在哺乳动物宿主的感染过程中被感染。重要的是,对这些的分子理解
机制对于克服有效抗病毒疗法的缺乏和对抗人类疾病至关重要。
果蝇的免疫反应与媒介昆虫的免疫反应高度同源,并且还具有惊人的共同点
与哺乳动物先天免疫相似。使用果蝇系统,我们之前发现
新兴的布尼亚病毒裂谷热病毒(RVFV)被果蝇模式识别受体感知
(PRR),Toll-7,可激活抗病毒自噬,并且这在哺乳动物细胞中是保守的。我们发现
TLR2 依赖性抗病毒自噬可以控制某些细胞类型中的 RVFV,而在其他细胞中则参与
TLR2 导致细胞死亡。此外,我们发现自噬的药理激活受到限制
哺乳动物初级神经元中的 RVFV,表明该途径可用于抗病毒保护。
由于 PRR 途径的组织特异性信号传导尚不清楚,我们筛选了一组 PRR 激动剂
那些可以同时阻断神经元和非神经元细胞中 RVFV 感染的药物。我们确定了两个
抗病毒 PAMP 类别。首先,我们确定 TLR2 激动剂对两种细胞类型都具有抗病毒作用。自从
我们建议,自噬的药理激活可以保护原代哺乳动物神经元免受感染
TLR2 激活可用于保护神经元免受脑炎病毒的侵害。其次,我们确定了
Dectin-1 激动剂在神经元中具有特异性抗病毒作用,这一点将得到进一步探索。因此,从长远来看
拟议研究的目的是了解病毒感染的分子机制
由先天途径感知和控制,以及如何利用它来诱导保护性
包括神经元在内的多种细胞类型的防御。为了实现这些目标,本申请提出了两个
具体目标:(1) 确定 TLR2 感知 RVFV 并导致不同结果的机制,
自噬或细胞死亡; (2)探索成熟哺乳动物中控制布尼亚病毒的PRR途径
神经元。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sara Cherry其他文献
Sara Cherry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sara Cherry', 18)}}的其他基金
Development and validation of antivirals against Flaviviruses
黄病毒抗病毒药物的开发和验证
- 批准号:
10514328 - 财政年份:2022
- 资助金额:
$ 52.1万 - 项目类别:
Defining the role of microbiota-derived cyclic dinucleotides in priming antiviral immune defenses.
定义微生物群衍生的环状二核苷酸在启动抗病毒免疫防御中的作用。
- 批准号:
10551893 - 财政年份:2020
- 资助金额:
$ 52.1万 - 项目类别:
Small Molecule Screening to Identify Novel Sars-CoV-2 Therapeutics
通过小分子筛选鉴定新型 Sars-CoV-2 疗法
- 批准号:
10223018 - 财政年份:2020
- 资助金额:
$ 52.1万 - 项目类别:
Defining the role of microbiota-derived cyclic dinucleotides in priming antiviral immune defenses.
定义微生物群衍生的环状二核苷酸在启动抗病毒免疫防御中的作用。
- 批准号:
10326823 - 财政年份:2020
- 资助金额:
$ 52.1万 - 项目类别:
The role of pattern recognition and autophagy in innate anti-bunyaviral immunity
模式识别和自噬在先天性抗布尼亚病毒免疫中的作用
- 批准号:
10468096 - 财政年份:2019
- 资助金额:
$ 52.1万 - 项目类别:
Small Molecule Screening to Identify Novel Sars-CoV-2 Therapeutics
通过小分子筛选鉴定新型 Sars-CoV-2 疗法
- 批准号:
10239297 - 财政年份:2019
- 资助金额:
$ 52.1万 - 项目类别:
The role of pattern recognition and autophagy in innate anti-bunyaviral immunity
模式识别和自噬在先天性抗布尼亚病毒免疫中的作用
- 批准号:
10686406 - 财政年份:2019
- 资助金额:
$ 52.1万 - 项目类别:
The role of pattern recognition and autophagy in innate anti-bunyaviral immunity
模式识别和自噬在先天性抗布尼亚病毒免疫中的作用
- 批准号:
10222526 - 财政年份:2019
- 资助金额:
$ 52.1万 - 项目类别:
The role of pattern recognition and autophagy in innate anti-bunyaviral immunity
模式识别和自噬在先天性抗布尼亚病毒免疫中的作用
- 批准号:
10673509 - 财政年份:2019
- 资助金额:
$ 52.1万 - 项目类别:
The role of pattern recognition and autophagy in innate anti-bunyaviral immunity
模式识别和自噬在先天性抗布尼亚病毒免疫中的作用
- 批准号:
10023159 - 财政年份:2019
- 资助金额:
$ 52.1万 - 项目类别:
相似国自然基金
脂质纳米粒体内介导嵌合抗原受体-M1型巨噬细胞协同TLR激动剂治疗实体瘤的研究
- 批准号:82304418
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型共享新生抗原肽-STING激动剂偶联物的构建、免疫抗肿瘤活性及作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
双功能STING激动剂介导抗原靶向内质网提升CD8+T细胞免疫应答
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
负载抗原肽和TLR9激动剂的纳米载体靶向树突状细胞增强肝癌射频消融术后肿瘤特异性T细胞免疫应答
- 批准号:81873920
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
新型TLR4激动剂用于肿瘤相关糖抗原疫苗的构建与优化及其抗肿瘤免疫活性研究
- 批准号:81773580
- 批准年份:2017
- 资助金额:58.5 万元
- 项目类别:面上项目
相似海外基金
The role of osteoblast progenitors in response to bone anabolic agents
成骨细胞祖细胞对骨合成代谢剂的反应的作用
- 批准号:
10404415 - 财政年份:2023
- 资助金额:
$ 52.1万 - 项目类别:
Cellular and Metabolic Dysfunction in Sepsis-Induced Immune Paralysis
脓毒症引起的免疫麻痹中的细胞和代谢功能障碍
- 批准号:
10724018 - 财政年份:2023
- 资助金额:
$ 52.1万 - 项目类别:
Project 2: Mechanisms of Resistance to Neoantigen Vaccines in PDAC
项目2:PDAC新抗原疫苗耐药机制
- 批准号:
10708575 - 财政年份:2023
- 资助金额:
$ 52.1万 - 项目类别:
Tumor-Targeted Multimodality Nanoscale Coordination Polymers for Chemo-Immunotherapy of Metastatic Colorectal Cancer
用于转移性结直肠癌化疗免疫治疗的肿瘤靶向多模态纳米配位聚合物
- 批准号:
10639649 - 财政年份:2023
- 资助金额:
$ 52.1万 - 项目类别:
Harnessing activated CD4 T cells to define new mechanisms of protection in tuberculosis
利用活化的 CD4 T 细胞定义结核病的新保护机制
- 批准号:
10735439 - 财政年份:2023
- 资助金额:
$ 52.1万 - 项目类别: